Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Economic analyses and lung cancer.

A Vergnenègre1, L Molinier, C Chouaïd

  • 1Service de l'Information Médicale et de l'Evaluation, Service de Pneumologie, Hôpital Universitaire du Cluzeau, 23, avenue Dominique-Larrey, 87042 Limoges, France. avergne@unilim.fr

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|January 5, 2002
PubMed
Summary

Economic assessments of medical treatments, especially for chronic diseases like lung cancer, are crucial due to high costs and varying efficacy. This review covers the theory, tools, and application of economic evaluations in lung cancer treatment, highlighting their future clinical importance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimisation and validation of line-of-therapy advancement algorithms in advanced/metastatic non-small-cell lung cancer: an I-O Optimise study.

ESMO real world data and digital oncology·2026
Same author

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC.

ESMO open·2026
Same author

Prediction of survival and outcomes with depth of response at 6 months in metastatic non-small-cell lung cancer patients treated with chemotherapy and immunotherapy combination: SPORE trial.

ESMO open·2026
Same author

Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis.

ESMO open·2025
Same author

Durvalumab after sequential chemoradiotherapy in unresectable stage III non-small-cell lung cancer-final analysis from the phase II PACIFIC-6 trial.

ESMO open·2025
Same author

[Influence of smoking on the efficacy of immunotherapy in advanced lung cancers].

Revue des maladies respiratoires·2025

Area of Science:

  • Health Economics
  • Oncology
  • Clinical Decision-Making

Background:

  • Increasing publications on economic assessments of medical treatments.
  • High costs and limited efficacy of chronic disease treatments, like lung cancer, necessitate economic analyses.
  • Growing need for cost-effectiveness evaluations in healthcare.

Purpose of the Study:

  • To review the theoretical basis, tools, and limitations of economic assessment methods.
  • To examine the application of economic assessments in lung cancer treatment.
  • To outline the future role of economic considerations for clinicians.

Main Methods:

  • Literature review of theoretical frameworks for economic assessment.
  • Analysis of economic evaluation tools and their limitations.

Related Experiment Videos

  • Case study application to lung cancer treatment strategies.

    • Main Results:

    • Economic assessment provides complementary data for clinical decision-making.
    • Methods include evaluating societal costs of cancer and cost-effectiveness of chemotherapy.
    • Cost-effectiveness analysis is relevant in randomized trials.

    Conclusions:

    • Economic assessment methods are valuable for clinicians in choosing therapeutic options.
    • These methods are expected to gain wider adoption in clinical practice.
    • Economic evaluations enhance the understanding of treatment value in oncology.